Golatta M - Search Results

1

Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance.

Surowy HM, Sutter C, Mittnacht M, Klaes R, Schaefer D, Evers C, Burgemeister AL, Goehringer C, Dikow N, Heil J, Golatta M, Schott S, Schneeweiss A, Bugert P, Sohn C, Bartram CR, Burwinkel B. Surowy HM, et al. Among authors: golatta m. Breast Cancer Res Treat. 2014 Jun;145(2):451-60. doi: 10.1007/s10549-014-2943-5. Epub 2014 Apr 12. Breast Cancer Res Treat. 2014. PMID: 24728577

2

Best Practice Guideline - DEGUM Recommendations on Breast Ultrasound.

Vogel-Minea CM, Bader W, Blohmer JU, Duda V, Eichler C, Fallenberg EM, Farrokh A, Golatta M, Gruber I, Hackelöer BJ, Heil J, Madjar H, Marzotko E, Merz E, Müller-Schimpfle M, Mundinger A, Ohlinger R, Peisker U, Schäfer FK, Schulz-Wendtland R, Solbach C, Warm M, Watermann D, Wojcinski S, Dudwiesus H, Hahn M. Vogel-Minea CM, et al. Among authors: golatta m. Ultraschall Med. 2023 Oct;44(5):520-536. doi: 10.1055/a-2020-9904. Epub 2023 Apr 18. Ultraschall Med. 2023. PMID: 37072031 Free article. English, German.

3

Aesthetic and functional results after breast conserving surgery as correlates of quality of life measured by a German version of the Breast Cancer Treatment Outcome Scale (BCTOS).

Heil J, Holl S, Golatta M, Rauch G, Rom J, Marmé F, Gebauer G, Sohn C. Heil J, et al. Among authors: golatta m. Breast. 2010 Dec;19(6):470-4. doi: 10.1016/j.breast.2010.05.004. Epub 2010 Jun 3. Breast. 2010. PMID: 20627726 Free article.

4

Aesthetics in breast conserving therapy: do objectively measured results match patients' evaluations?

Heil J, Dahlkamp J, Golatta M, Rom J, Domschke C, Rauch G, Cardoso MJ, Sohn C. Heil J, et al. Among authors: golatta m. Ann Surg Oncol. 2011 Jan;18(1):134-8. doi: 10.1245/s10434-010-1252-4. Epub 2010 Aug 10. Ann Surg Oncol. 2011. PMID: 20697820 Clinical Trial.

5

Change of aesthetic and functional outcome over time and their relationship to quality of life after breast conserving therapy.

Heil J, Czink E, Golatta M, Schott S, Hof H, Jenetzky E, Blumenstein M, Maleika A, Rauch G, Sohn C. Heil J, et al. Among authors: golatta m. Eur J Surg Oncol. 2011 Feb;37(2):116-21. doi: 10.1016/j.ejso.2010.11.007. Epub 2010 Dec 3. Eur J Surg Oncol. 2011. PMID: 21130597

6

Does a supplementary preoperative breast MRI in patients with invasive lobular breast cancer change primary and secondary surgical interventions?

Heil J, Bühler A, Golatta M, Rom J, Harcos A, Schipp A, Rauch G, Junkermann H, Sohn C. Heil J, et al. Among authors: golatta m. Ann Surg Oncol. 2011 Aug;18(8):2143-9. doi: 10.1245/s10434-011-1565-y. Epub 2011 Feb 3. Ann Surg Oncol. 2011. PMID: 21290193 Clinical Trial.

7

Do patients with invasive lobular breast cancer benefit in terms of adequate change in surgical therapy from a supplementary preoperative breast MRI?

Heil J, Buehler A, Golatta M, Rom J, Schipp A, Harcos A, Schneeweiss A, Rauch G, Sohn C, Junkermann H. Heil J, et al. Among authors: golatta m. Ann Oncol. 2012 Jan;23(1):98-104. doi: 10.1093/annonc/mdr064. Epub 2011 Apr 2. Ann Oncol. 2012. PMID: 21460377 Free article.

8

Do reexcisions impair aesthetic outcome in breast conservation surgery? Exploratory analysis of a prospective cohort study.

Heil J, Breitkreuz K, Golatta M, Czink E, Dahlkamp J, Rom J, Schuetz F, Blumenstein M, Rauch G, Sohn C. Heil J, et al. Among authors: golatta m. Ann Surg Oncol. 2012 Feb;19(2):541-7. doi: 10.1245/s10434-011-1947-1. Epub 2011 Jul 15. Ann Surg Oncol. 2012. PMID: 21761099 Clinical Trial.

9

Objective assessment of aesthetic outcome after breast conserving therapy: subjective third party panel rating and objective BCCT.core software evaluation.

Heil J, Carolus A, Dahlkamp J, Golatta M, Domschke C, Schuetz F, Blumenstein M, Rauch G, Sohn C. Heil J, et al. Among authors: golatta m. Breast. 2012 Feb;21(1):61-5. doi: 10.1016/j.breast.2011.07.013. Epub 2011 Aug 17. Breast. 2012. PMID: 21852135 Free article.

10

Molecular and clinical characterization of an in frame deletion of uncertain clinical significance in the BRCA2 gene.

Rath MG, Fathali-Zadeh F, Langheinz A, Tchatchou S, Voigtländer T, Heil J, Golatta M, Schott S, Drasseck T, Behnecke A, Burgemeister AL, Evers C, Bugert P, Junkermann H, Schneeweiss A, Bartram CR, Sohn C, Sutter C, Burwinkel B. Rath MG, et al. Among authors: golatta m. Breast Cancer Res Treat. 2012 Jun;133(2):725-34. doi: 10.1007/s10549-011-1917-0. Epub 2012 Jan 8. Breast Cancer Res Treat. 2012. PMID: 22228431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page